Patents by Inventor Jaroslav Kyncl
Jaroslav Kyncl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 4166819Abstract: This invention provides 4-aroyl substituted phenoxy acetic acids and tetrazoles of the formula ##STR1## wherein R is a phenyl ring, a substituted phenyl ring, or naphthyl; R.sub.1 is --CH.sub.2 COOH or methyl tetrazole, and X.sub.1 and X.sub.2 are each a halogen or loweralkyl, or when taken together form with the two attached carbons a phenyl ring.These compounds are useful as antihypertensive agents, diuretics and uricosuric agents.Type: GrantFiled: September 6, 1977Date of Patent: September 4, 1979Assignee: Abbott LaboratoriesInventors: Peter H. Jones, Dilbagh S. Bariana, Anthony K. L. Fung, Yvonne C. Martin, Jaroslav Kyncl, Amrit Lall
-
Patent number: 4112097Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyquinazo line, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.Type: GrantFiled: January 21, 1977Date of Patent: September 5, 1978Assignee: Abbott LaboratoriesInventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Hadley Jones
-
Patent number: 4105787Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.Type: GrantFiled: May 3, 1977Date of Patent: August 8, 1978Assignee: Abbott LaboratoriesInventors: Peter H. Jones, Carroll W. Curs, Jaroslav Kyncl
-
Patent number: 4105788Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.Type: GrantFiled: May 3, 1977Date of Patent: August 8, 1978Assignee: Abbott LaboratoriesInventors: Peter H. Jones, Carroll W. Curs, Jaroslav Kyncl
-
Patent number: 4093726Abstract: Disclosed are compounds of the formula ##STR1## wherein n is 2 or 3, R is hydrogen or methyl, R' is C.sub.1 -C.sub.6 alkyl, acyl, aryl, aroyl, alkoxycarbonyl, tetrahydrofuroyl, dialkylaminocarbonyl, or furoyl, and R" is hydrogen and methoxy. These compounds are useful as antihypertensive agents.Type: GrantFiled: December 2, 1976Date of Patent: June 6, 1978Assignee: Abbott LaboratoriesInventors: Martin Winn, Jaroslav Kyncl
-
Patent number: 4088765Abstract: Described are the compounds 5,6-dimethoxy-2-(4-benzyl-1-piperidino) benzimidazole and 5,6-dimethoxy-2 (6,7-dimethoxy-1,2,3,4-tetrahydro 2-isoquinolinyl benzimidazole and pharmaceutically acceptable acid addition salts thereof. The compounds are useful as antihypertensive agents.Type: GrantFiled: December 2, 1976Date of Patent: May 9, 1978Assignee: Abbott LaboratoriesInventors: Martin Winn, Jaroslav Kyncl
-
Patent number: 4058559Abstract: This invention provides 4-aroyl substituted phenoxy acetic acids and tetrazoles of the formula ##STR1## wherein R is a phenyl ring, a substituted phenyl ring, or naphthyl; R.sub.1 is --CH.sub.2 COOH or methyl tetrazole, and X.sub.1 and X.sub.2 are each a halogen or loweralkyl, or when taken together form with the two attached carbons a phenyl ring.These compounds are useful as antihypertensive agents, diuretics and uricosuric agents.Type: GrantFiled: September 24, 1975Date of Patent: November 15, 1977Assignee: Abbott LaboratoriesInventors: Peter Hadley Jones, Dilbagh Singh Bariana, Anthony Kei Lun Fung, Yvonne Connolly Martin, Jaroslav Kyncl, Amrit Lall
-
Patent number: 4044135Abstract: Described are the compounds 2[4(tetrahydro-2-furoyl)-hexahydro-1,4-diazepinyl-1]-4-amino-6,7-dimethoxy quinazoline and pharmaceutically acceptable acid addition salts thereof. The compounds are useful as antihypertensive agents.Type: GrantFiled: October 14, 1975Date of Patent: August 23, 1977Assignee: Abbott LaboratoriesInventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Handley Jones
-
Patent number: 4031242Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.Type: GrantFiled: September 11, 1975Date of Patent: June 21, 1977Assignee: Abbott LaboratoriesInventors: Peter Hadley Jones, Carroll Wayne Ours, Jaroslav Kyncl
-
Patent number: 4026894Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyquinazo line, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.Type: GrantFiled: October 14, 1975Date of Patent: May 31, 1977Assignee: Abbott LaboratoriesInventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Hadley Jones
-
Patent number: 4017636Abstract: Covers the esters of .gamma.-glutamyl amide of dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.18 alkyl radical, and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said esters of .gamma.-glutamyl amide of dopamine to increase renal blood flow by administering said amide to warm-blooded mammals by clinically acceptable routes of administration such as oral, parenteral, rectal, etc.Type: GrantFiled: September 24, 1975Date of Patent: April 12, 1977Assignee: Abbott LaboratoriesInventors: Peter Hadley Jones, Jaroslav Kyncl, Carroll Wayne Ours, Pitambar Somani
-
Patent number: 3947590Abstract: Covers a .gamma.-glutamyl amide of dopamine selected from the group consisting of ##EQU1## and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said .gamma.-glutamyl amide to increase renal blood flow by administering said amide to warm-blooded mammals.Type: GrantFiled: January 27, 1975Date of Patent: March 30, 1976Assignee: Abbott LaboratoriesInventors: Jaroslav Kyncl, Kathleen Riley Lynn, Yvonne Connolly Martin, Carroll Wayne Ours